Healthcare

Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.

Across the board, Americans are slightly less interested in taking medications like GLP-1 drugs to reduce cravings for eating, drinking alcohol or gambling, according to new data from the Ipsos Consumer Tracker

Join Ipsos' Ayse Levent showcasing insights from our MASH Therapy Monitor on November 8.

Built on the foundation of Ipsos’ gold-standard Global Healthcare Monitors, the Ipsos Rx Insight Store offers standardised reports and dashboards that empower biopharma companies to make rapid, informed decisions for brand success.

Read more about the recent breakthroughs, ongoing challenges, and future directions of Alzheimer’s disease pharmacotherapy.

Findings of a new Ipsos poll offered exclusively to Axios on the importance of anti-smoking campaigns and whether Americans feel these campaigns should be strengthened or weakened

New NAMI/Ipsos poll reveals calls for expanded support of the 988 Lifeline and mental health crisis response in the U.S., but more information on specifics of 988 funding is needed

How our changing world is impacting our cells, and what it means for all of us.

Ipsos Research Examines Awareness, Attitudes and Trust of Psychedelics in Mental Health Treatment